CN104246497B - 疾病样品分析装置、分析系统及分析方法 - Google Patents

疾病样品分析装置、分析系统及分析方法 Download PDF

Info

Publication number
CN104246497B
CN104246497B CN201380019921.6A CN201380019921A CN104246497B CN 104246497 B CN104246497 B CN 104246497B CN 201380019921 A CN201380019921 A CN 201380019921A CN 104246497 B CN104246497 B CN 104246497B
Authority
CN
China
Prior art keywords
mice
amino acid
disease
concentration
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380019921.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN104246497A (zh
Inventor
浜濑健司
东條洋介
三田真史
水本智惠子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mirror Co ltd
Original Assignee
Kyushu University NUC
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CN201910585530.XA priority Critical patent/CN110133296B/zh
Priority to CN201910585495.1A priority patent/CN110133295A/zh
Priority to CN201910591882.6A priority patent/CN110161256B/zh
Priority to CN202210524153.0A priority patent/CN114966050A/zh
Priority to CN201910585588.4A priority patent/CN110133297A/zh
Priority to CN201910591893.4A priority patent/CN110133301B/zh
Priority to CN201710913596.8A priority patent/CN107449923B/zh
Priority to CN201910586450.6A priority patent/CN110133300B/zh
Application filed by Kyushu University NUC, Shiseido Co Ltd filed Critical Kyushu University NUC
Priority to CN201910586159.9A priority patent/CN110133299A/zh
Priority to CN201910585649.7A priority patent/CN110133298A/zh
Publication of CN104246497A publication Critical patent/CN104246497A/zh
Application granted granted Critical
Publication of CN104246497B publication Critical patent/CN104246497B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/89—Inverse chromatography
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8818—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8877—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201380019921.6A 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法 Expired - Fee Related CN104246497B (zh)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CN201910591882.6A CN110161256B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN202210524153.0A CN114966050A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585588.4A CN110133297A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910591893.4A CN110133301B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910586450.6A CN110133300B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910586159.9A CN110133299A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585530.XA CN110133296B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585495.1A CN110133295A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585649.7A CN110133298A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201710913596.8A CN107449923B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012061305 2012-03-18
JP2012-061305 2012-03-18
PCT/JP2013/001849 WO2013140785A1 (ja) 2012-03-18 2013-03-18 疾患サンプル分析装置、分析システム及び分析方法

Related Child Applications (10)

Application Number Title Priority Date Filing Date
CN201910586159.9A Division CN110133299A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910591882.6A Division CN110161256B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585495.1A Division CN110133295A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585588.4A Division CN110133297A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201710913596.8A Division CN107449923B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585649.7A Division CN110133298A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910586450.6A Division CN110133300B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585530.XA Division CN110133296B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN202210524153.0A Division CN114966050A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910591893.4A Division CN110133301B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法

Publications (2)

Publication Number Publication Date
CN104246497A CN104246497A (zh) 2014-12-24
CN104246497B true CN104246497B (zh) 2017-10-13

Family

ID=49222264

Family Applications (11)

Application Number Title Priority Date Filing Date
CN201380019921.6A Expired - Fee Related CN104246497B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910591893.4A Active CN110133301B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910586450.6A Expired - Fee Related CN110133300B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910591882.6A Active CN110161256B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585649.7A Pending CN110133298A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585495.1A Pending CN110133295A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585588.4A Pending CN110133297A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN202210524153.0A Pending CN114966050A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910586159.9A Pending CN110133299A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585530.XA Active CN110133296B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201710913596.8A Expired - Fee Related CN107449923B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法

Family Applications After (10)

Application Number Title Priority Date Filing Date
CN201910591893.4A Active CN110133301B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910586450.6A Expired - Fee Related CN110133300B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910591882.6A Active CN110161256B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585649.7A Pending CN110133298A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585495.1A Pending CN110133295A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585588.4A Pending CN110133297A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN202210524153.0A Pending CN114966050A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910586159.9A Pending CN110133299A (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201910585530.XA Active CN110133296B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法
CN201710913596.8A Expired - Fee Related CN107449923B (zh) 2012-03-18 2013-03-18 疾病样品分析装置、分析系统及分析方法

Country Status (7)

Country Link
US (2) US20150079623A1 (enExample)
EP (3) EP3663758A1 (enExample)
JP (3) JP6037388B2 (enExample)
CN (11) CN104246497B (enExample)
IN (1) IN2014MN02060A (enExample)
TW (2) TWI664425B (enExample)
WO (1) WO2013140785A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015087985A1 (ja) 2013-12-11 2015-06-18 株式会社資生堂 腎不全の早期診断マーカー
HK1251299A1 (en) * 2015-06-10 2019-01-25 Kanazawa University Disease-state biomarker for renal disease
CN108587991B (zh) * 2015-10-10 2021-03-05 中国科学院南海海洋研究所 一种高产环肽类化合物的菌株
WO2017200025A1 (ja) * 2016-05-17 2017-11-23 国立大学法人大阪大学 糖尿病を判定するための血液試料の分析方法及びシステム
EP3460477A4 (en) * 2016-05-17 2020-01-08 Osaka University METHOD AND SYSTEM FOR PROGNOSING FORECAST OF A KIDNEY DISEASE
EP3543690A4 (en) 2016-11-15 2020-05-27 Shiseido Company, Ltd. MULTI-DIMENSIONAL CHROMATOGRAPHIC ANALYSIS PROCESS AND ANALYSIS SYSTEM
WO2018159833A1 (ja) * 2017-03-02 2018-09-07 株式会社ニコン 細胞の判別方法、がんの検査方法、計測装置、がんの検査装置および検査プログラム
EP3590937A4 (en) 2017-03-03 2021-03-10 Shiseido Company Ltd. NOVEL COMPOUND, FLUORESCENT DERIVATIZATION REAGENT WITH THE ABOVE NOVEL COMPOUND, METHOD OF OPTICAL RESOLUTION OF AN OPTICAL ISOMER OF AMINO ACID USING THE ABOVE NOVEL COMPOUND, AND FLUORESCENT
CN112469404A (zh) * 2018-06-07 2021-03-09 国立大学法人金泽大学 肾损伤的预防或治疗用的药物组合物
WO2020045364A1 (ja) * 2018-08-27 2020-03-05 株式会社 資生堂 乾癬を判定するための皮膚試料の分析方法及びシステム
JP6868878B2 (ja) 2018-10-17 2021-05-12 Kagami株式会社 糸球体濾過能力の決定方法
JP7715389B2 (ja) 2019-03-22 2025-07-30 Kagami株式会社 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム
US20220170945A1 (en) * 2019-03-22 2022-06-02 Kagami Inc. Method for assisting evaluation of renal pathological conditions, system for evaluating renal pathological conditions and program for evaluating renal pathological conditions
JP7434678B2 (ja) * 2019-05-20 2024-02-21 花王株式会社 認知症又はそのリスクの検査方法
EP4083628B1 (en) 2019-12-27 2026-03-11 Kagami Inc. Method and system for estimating renal function
CN112180007B (zh) * 2020-09-16 2023-08-18 上海市皮肤病医院 基于代谢组学的泛发性脓疱型银屑病诊断标志物及其应用
CN111899883B (zh) * 2020-09-29 2020-12-15 平安科技（深圳）有限公司 少样本或零样本的疾病预测设备、方法、装置及存储介质
JP7600016B2 (ja) * 2021-03-30 2024-12-16 花王株式会社 高次脳機能の測定方法
WO2023033178A1 (ja) * 2021-09-03 2023-03-09 Kagami株式会社 癌についての情報を提供する方法、癌についての情報を提供するシステム及び癌を治療する方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4290893A (en) * 1979-05-08 1981-09-22 Yeda Research & Development Co. Ltd. Separation of amino acids by liquid chromatography using chiral eluants
NZ236114A (en) * 1989-11-22 1993-04-28 Merrell Dow Pharma Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
WO1996028470A2 (en) * 1995-03-09 1996-09-19 Neurocrine Biosciences, Inc. Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
JPH0975078A (ja) * 1995-09-13 1997-03-25 Ikeda Shokken Kk 耐熱性ｄ−アミノ酸オキシダーゼ、その製造法および微生物
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
ATE251308T1 (de) * 1998-06-11 2003-10-15 Fox Chase Cancer Ct Methoden zur ermittlung des risikos eines diabetikers für einen mit diabetes in zusammenhang stehenden pathologischen zustand
AU775563B2 (en) * 1999-05-14 2004-08-05 Brandeis University Nucleic acid-based detection
US6479063B2 (en) * 1999-12-27 2002-11-12 Kenneth Weisman Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis
US7223558B2 (en) * 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
FR2828693B1 (fr) * 2001-08-14 2004-06-18 Exonhit Therapeutics Sa Nouvelle cible moleculaire de la neurotoxicite
CA2475953A1 (en) * 2002-02-27 2003-09-04 E. Ann Tallant Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
FR2838444B1 (fr) * 2002-04-10 2016-01-01 Neovacs Nouveaux peptides et leur application en therapeutique
US20070298041A1 (en) * 2002-06-28 2007-12-27 Tomlinson Ian M Ligands That Enhance Endogenous Compounds
JP4299243B2 (ja) * 2002-07-04 2009-07-22 田辺三菱製薬株式会社 統合失調症の検査、診断方法
GB0219776D0 (en) * 2002-08-24 2002-10-02 Oxford Glycosciences Uk Ltd A protein involved in carcinoma
GB0223424D0 (en) * 2002-10-09 2002-11-13 Imp College Innovations Ltd Disease-associated gene
KR100686910B1 (ko) * 2002-12-09 2007-02-26 아지노모토 가부시키가이샤 생체 상태 정보 처리 장치, 생체 상태 정보 처리 방법, 생체 상태 정보 관리 시스템 및 기록 매체
AU2003292696A1 (en) * 2002-12-26 2004-08-10 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
AU2003900777A0 (en) * 2003-02-21 2003-03-13 Medvet Science Pty. Ltd. A method of diagnosis and treatment
CA2518703A1 (en) * 2003-03-10 2004-09-23 Sionex Corporation Systems for differential ion mobility analysis
US20060217316A1 (en) * 2003-04-02 2006-09-28 Ragab El-Rashidy Method for the treatment of prostate cancer
JP4291628B2 (ja) 2003-06-12 2009-07-08 株式会社資生堂 液体クロマトグラフ装置及び試料に含まれる光学異性体の分析方法
CN1557823A (zh) * 2004-02-12 2004-12-29 窦德献 L-或d-氨基酸合铂配位体、制备方法及其用途
DE602005025211D1 (de) * 2004-04-09 2011-01-20 Us Gov Health & Human Serv Diagnosegerät zur diagnose gutartiger gegenüber bösartigen schilddrüsenläsionen
AT500483B1 (de) * 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
GB0417887D0 (en) * 2004-08-11 2004-09-15 Ares Trading Sa Protein
ES2594885T3 (es) * 2005-03-18 2016-12-23 Shiseido Company, Limited Método para evaluar una enfermedad de la piel utilizando un antígeno relacionado con el carcinoma de células escamosas como medida
CN101189243A (zh) * 2005-04-06 2008-05-28 阿斯利康(瑞典)有限公司 取代的杂环及其作为chk1、pdk1和pak抑制剂的应用
JP2007077104A (ja) * 2005-09-16 2007-03-29 Shiseido Co Ltd 血管内皮増殖因子阻害剤
US20080073500A1 (en) * 2006-03-02 2008-03-27 Perkinelmer Las, Inc. Distinguishing Isomers Using Mass Spectrometry
US20070258899A1 (en) * 2006-03-31 2007-11-08 Karyon-Ctt Ltd Diagnostic and therapeutic agents
JP5005955B2 (ja) * 2006-05-24 2012-08-22 田辺三菱製薬株式会社 被験物質の脂質代謝異常症誘発可能性を予測する方法
JP5399900B2 (ja) * 2006-06-30 2014-01-29 メルク・シャープ・アンド・ドーム・コーポレーション Ｉｇｆｂｐ２インヒビター
CN101578287B (zh) * 2006-09-06 2012-09-05 阿特纳赞塔里斯有限公司 地索拉唑及其衍生物与细胞结合分子的轭合物，新的地索拉唑衍生物，其制备方法及其应用
EP1900742A1 (en) * 2006-09-07 2008-03-19 AEterna Zentaris GmbH Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
EP2074092A2 (en) * 2007-01-18 2009-07-01 Sepracor Inc. Inhibitors of d-amino acid oxidase
EP2129775A1 (en) * 2007-02-12 2009-12-09 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
US8034780B2 (en) * 2007-07-16 2011-10-11 Mcphail Kerry Leigh Isolation, purification, and structure elucidation of the antiproliferative compound coibamide A
CA2712309A1 (en) * 2008-01-17 2009-07-23 Toray Industries, Inc. Composition and method for diagnosis or detection of renal cancer
JP2009184981A (ja) * 2008-02-07 2009-08-20 Shiseido Co Ltd 抗ｄ−アミノ酸モノクローナル抗体及び、抗ｄ−アミノ酸モノクローナル抗体を用いたｄ−アミノ酸の免疫学的分析方法
CL2009001156A1 (es) * 2008-05-14 2010-08-27 Canbas Co Ltd Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares.
WO2009143489A2 (en) * 2008-05-22 2009-11-26 Archer Pharmaceuticals, Inc. Modulation of angiogenesis by a-beta peptide fragments
US20110311650A1 (en) * 2008-07-07 2011-12-22 Thomas Wang Multiplexed biomarkers of insulin resistance
JP2010038796A (ja) * 2008-08-06 2010-02-18 Human Metabolome Technologies Inc 疾患マーカー、および、疾患マーカーの測定方法
US8592642B2 (en) * 2008-08-26 2013-11-26 Kyushu University, National University Corporation Evaluation/screening method for diseases associated with D-amino acid utilizing DAO1-/-mouse
WO2010057647A2 (en) * 2008-11-21 2010-05-27 Universita' Degli Studi Di Milano Methods and compositions for the diagnosis and treatment of diabetes
ES2799327T3 (es) * 2009-05-05 2020-12-16 Infandx Ag Método para diagnosticar asfixia
CN101619092B (zh) * 2009-08-06 2012-08-15 中国人民解放军第三军医大学第二附属医院 肿瘤抗原trag-3模拟表位肽及其应用
US20110064828A1 (en) * 2009-09-11 2011-03-17 Novelos Therapeutics, Incorporated Treatment of metastatic tumors and other conditions
JP2011247869A (ja) * 2010-04-27 2011-12-08 Kobe Univ メタボローム解析手法を用いた特定疾患の検査方法
CN102079771B (zh) * 2010-12-10 2012-10-03 郑州大学 具有抗肿瘤活性的雌甾氨基酸酯化合物及其合成方法

Also Published As

Publication number Publication date
JP6037388B2 (ja) 2016-12-07
EP3795997B1 (en) 2022-08-24
IN2014MN02060A (enExample) 2015-08-21
JP2017223711A (ja) 2017-12-21
JP2017015741A (ja) 2017-01-19
EP2829877A1 (en) 2015-01-28
CN110161256A (zh) 2019-08-23
CN110161256B (zh) 2022-03-25
CN110133296B (zh) 2022-03-25
WO2013140785A1 (ja) 2013-09-26
US20150079623A1 (en) 2015-03-19
TW201736851A (zh) 2017-10-16
JP2013224929A (ja) 2013-10-31
CN110133299A (zh) 2019-08-16
CN107449923A (zh) 2017-12-08
CN107449923B (zh) 2020-07-24
CN110133297A (zh) 2019-08-16
US20190025320A1 (en) 2019-01-24
CN114966050A (zh) 2022-08-30
EP3795997A1 (en) 2021-03-24
EP2829877B1 (en) 2020-01-22
CN110133301A (zh) 2019-08-16
TW201344194A (zh) 2013-11-01
EP2829877A4 (en) 2015-12-09
CN110133300A (zh) 2019-08-16
CN110133296A (zh) 2019-08-16
TWI615614B (zh) 2018-02-21
CN110133300B (zh) 2022-02-25
JP6391787B2 (ja) 2018-09-19
JP6214016B2 (ja) 2017-10-18
CN110133301B (zh) 2022-03-22
CN110133298A (zh) 2019-08-16
EP3663758A1 (en) 2020-06-10
CN104246497A (zh) 2014-12-24
TWI664425B (zh) 2019-07-01
CN110133295A (zh) 2019-08-16

Similar Documents

Publication Publication Date Title
CN104246497B (zh) 疾病样品分析装置、分析系统及分析方法
JP2013224929A5 (enExample)
US20190339281A1 (en) Marker for early diagnosis of kidney failure
Del Amo et al. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
Zhong et al. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice
US20220003774A1 (en) Kidney disease prognosis prediction method and system
JP2026010183A (ja) 猫の腎機能障害の検査方法
AU771445B2 (en) Method for prediction of PTH reactivity by polymorphism of PTHR gene
Almehdi et al. Untargeted Metabolomics Reveals Unique Biomolecular Signatures in Overweight and Obesity Using UHPLC-ESI-QTOF-MS Analysis
HK40002816A (en) Kidney disease prognosis prediction method and system

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20180705

Address after: Tokyo, Japan

Patentee after: SHISEIDO Co.,Ltd.

Address before: Fukuoka Prefecture

Co-patentee before: SHISEIDO Co.,Ltd.

Patentee before: KYUSHU UNIVERSITY, NATIONAL University Corp.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200710

Address after: Osaka Japan

Patentee after: Mirror Co.,Ltd.

Address before: Tokyo, Japan

Patentee before: SHISEIDO Co.,Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171013

CF01 Termination of patent right due to non-payment of annual fee